Annovis up 23% after webinar on neurodegeneration candidates

Thinly traded nano cap Annovis Bio (ANVS +22.6%) bucks the broad market's bearishness, albeit on turnover of only 54K shares. After the close yesterday, CEO Maria Maccecchini, Ph .D., hosted an online Q&A session about recent developments at the company.


Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out